Literature DB >> 2777374

Chemical differences in lipopolysaccharides from Actinobacillus (Haemophilus) actinomycetemcomitans and Haemophilus aphrophilus: clues to differences in periodontopathogenic potential and taxonomic distinction.

I Brondz1, I Olsen.   

Abstract

While Actinobacillus actinomycetemcomitans has been associated with rapidly progressive periodontal destruction in man, the closely related Haemophilus aphrophilus has not been related to periodontal disease. This may be due to differences in composition and structure of the lipopolysaccharides (LPS) of these dental-plaque bacteria, since LPS probably exerts a series of detrimental effects on the periodontium. LPS was prepared by the phenol-water procedure from the type strains of A. actinomycetemcomitans and H. aphrophilus, purified by hexane extraction and ultracentrifugation, and analyzed with gas chromatography and gas chromatography-mass spectrometry. While the lipid content of LPS from A. actinomycetemcomitans constituted 35.4%, it was only 18.4% in H. aphrophilus: 3-hydroxytetradecanoic and tetradecanoic acids were 21.1 and 14.3% in A. actinomycetemcomitans and 10.9 and 7.5% in H. aphrophilus. There were qualitative and quantitative differences in the polysaccharide portions of their LPS. A actinomycetemcomitans contained both D-glycero-D-mannoheptose and L-glycero-D-mannoheptose (7.8 and 11.3%); H. aphrophilus contained only L-glycero-D-mannoheptose (17.4%). The rhamnose, fucose, galactose, glucose, and glucosamine/galactosamine contents in A. actinomycetemcomitans were 2.6, 5.2, 10.1, 22.4, and 5.2%, respectively; in H. aphrophilus, they were 2.1, 2.6, 19.4, 36.4, and 3.7%. Chemical differences in LPS from A. actinomycetemcomitans and H. aphrophilus may contribute to the divergence in periodontopathogenic potential of these organisms and help taxonomic differentiation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2777374      PMCID: PMC260776          DOI: 10.1128/iai.57.10.3106-3109.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Determination of bound cellular fatty acids in Actinobacillus actinomycetemcomitans and Haemophilus aphrophilus by gas chromatography and gas chromatography-mass spectrometry.

Authors:  I Brondz; I Olsen
Journal:  J Chromatogr       Date:  1984-06-08

Review 2.  Bacterial endotoxin: a role in chronic inflammatory periodontal disease?

Authors:  C G Daly; G J Seymour; J B Kieser
Journal:  J Oral Pathol       Date:  1980-01

3.  Chemical structure of the lipopolysaccharide of Haemophilus influenzae strain I-69 Rd-/b+. Description of a novel deep-rough chemotype.

Authors:  I M Helander; B Lindner; H Brade; K Altmann; A A Lindberg; E T Rietschel; U Zähringer
Journal:  Eur J Biochem       Date:  1988-11-15

4.  Characteristics of lipopolysaccharide-induced interleukin-1 production by human monocytes. Clinical relevance in patients undergoing hemodialysis.

Authors:  N Haeffner-Cavaillon; F Bacle; M Caroff; J M Cavaillon
Journal:  Prog Clin Biol Res       Date:  1988

5.  Production of interleukin-1 and tumor necrosis factor by human peripheral monocytes activated by periodontal bacteria and extracted lipopolysaccharides.

Authors:  R A Lindemann; J S Economou; H Rothermel
Journal:  J Dent Res       Date:  1988-08       Impact factor: 6.116

Review 6.  Chemotaxonomy of selected species of the Actinobacillus-Haemophilus-Pasteurella group by means of gas chromatography, gas chromatography-mass spectrometry and bioenzymatic methods.

Authors:  I Brondz; I Olsen
Journal:  J Chromatogr       Date:  1986-07-11

7.  Polysaccharides in vegetative and aggregation-competent amoebae of Dictyostelium discoideum. 2. Purification and characterization of amoeba-degraded bacterial polysaccharides.

Authors:  D Malchow; O Lüderitz; B Kickhöfen; O Westphal; G Gerisch
Journal:  Eur J Biochem       Date:  1969-01

8.  Modulation of bone metabolism by two chemically distinct lipopolysaccharide fractions from Bacteroides gingivalis.

Authors:  S J Millar; E G Goldstein; M J Levine; E Hausmann
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

9.  Suppression of murine macrophage interleukin-1 release by the polysaccharide portion of Haemophilus actinomycetemcomitans lipopolysaccharide.

Authors:  T Nishihara; T Koga; S Hamada
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

10.  Lipids of Bacteroides melaninogenicus.

Authors:  V Rizza; A N Tucker; D C White
Journal:  J Bacteriol       Date:  1970-01       Impact factor: 3.490

View more
  6 in total

1.  Evidence that the serotype b antigenic determinant of Actinobacillus actinomycetemcomitans Y4 resides in the polysaccharide moiety of lipopolysaccharide.

Authors:  M E Wilson; R E Schifferle
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

2.  Relationship between hydroxy fatty acids and prostaglandin E2 in gingival tissue.

Authors:  F Nichols; B Maraj
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

3.  Distribution of 3-hydroxy iC17:0 in subgingival plaque and gingival tissue samples: relationship to adult periodontitis.

Authors:  F C Nichols
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

4.  Multivariate analyses of cellular fatty acids in Bacteroides, Prevotella, Porphyromonas, Wolinella, and Campylobacter spp.

Authors:  I Brondz; I Olsen
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

Review 5.  Virulence and Pathogenicity Properties of Aggregatibacter actinomycetemcomitans.

Authors:  Georgios N Belibasakis; Terhi Maula; Kai Bao; Mark Lindholm; Nagihan Bostanci; Jan Oscarsson; Riikka Ihalin; Anders Johansson
Journal:  Pathogens       Date:  2019-11-06

6.  O-Polysaccharide Plays a Major Role on the Virulence and Immunostimulatory Potential of Aggregatibacter actinomycetemcomitans During Periodontal Infection.

Authors:  Gustavo Monasterio; Francisca Castillo; Jessica Astorga; Anilei Hoare; Claudia Terraza-Aguirre; Emilio A Cafferata; Eduardo J Villablanca; Rolando Vernal
Journal:  Front Immunol       Date:  2020-10-30       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.